Literature DB >> 8294430

Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase.

L Gandino1, P Longati, E Medico, M Prat, P M Comoglio.   

Abstract

The receptor for hepatocyte growth factor/scatter factor (HGF/SF) is an alpha beta tyrosine kinase of 190 kDa which mediates growth and motility in several cell types. We have previously shown that tyrosine autophosphorylation enhances the receptor kinase activity, while serine phosphorylation by protein kinase C or other Ca(2+)-dependent kinase(s) is inhibitory. We now identify Ser985 as the major phosphorylation site for the protein kinases responsible for such inhibition. Both phorbol esters or Ca2+ ionophore treatment induces phosphorylation of the same tryptic phosphopeptide corresponding to the sequence Leu983-Arg987 located in the juxta-membrane domain of the receptor beta chain. Purified protein kinase C phosphorylates in vitro a synthetic peptide (V14S) including Ser985. Trypsin digestion of the phosphorylated V14S generates a single phosphopeptide comigrating in reverse-phase high performance liquid chromatography with the tryptic peptide phosphorylated in vivo. Phorbol ester treatment of cultured cells inhibits the ligand-induced tyrosine autophosphorylation of the receptor. In vitro, Ser985 phosphorylation inhibits the receptor tyrosine kinase activity on exogenous substrates. Substitution of Ser985 by site-directed mutagenesis results in increased tyrosine phosphorylation of the receptor and abolishes down-modulation by protein kinase C. These data show that phosphorylation of Ser985 is a key mechanism for the negative regulation of HGF/SF receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  The serine and threonine residues in the Ig-alpha cytoplasmic tail negatively regulate immunoreceptor tyrosine-based activation motif-mediated signal transduction.

Authors:  R Müller; J Wienands; M Reth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 2.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage.

Authors:  David Tulasne; Julien Deheuninck; Filipe Calheiros Lourenco; Fabienne Lamballe; Zongling Ji; Catherine Leroy; Emilie Puchois; Anice Moumen; Flavio Maina; Patrick Mehlen; Véronique Fafeur
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

5.  Dephosphorylated Ser985 of c-Met is associated with acquired resistance to rechallenge injury in rats that had recovered from uranyl acetate-induced subclinical renal damage.

Authors:  Tomoyuki Fujikura; Akashi Togawa; Yuan Sun; Takamasa Iwakura; Hideo Yasuda; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2012-12-19       Impact factor: 2.801

Review 6.  The multiple paths towards MET receptor addiction in cancer.

Authors:  Leslie Duplaquet; Zoulika Kherrouche; Simon Baldacci; Philippe Jamme; Alexis B Cortot; Marie-Christine Copin; David Tulasne
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

Review 7.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

8.  MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

Authors:  Toshio Higuchi; Takuya Orita; Ken Katsuya; Yoshiki Yamasaki; Kiyotaka Akiyama; Huiping Li; Tadashi Yamamoto; Yutaka Saito; Motonao Nakamura
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 9.  c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.

Authors:  Martin Sattler; Ravi Salgia
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

10.  Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor.

Authors:  Massimo M Santoro; Giovanni Gaudino; Emma Villa-Moruzzi
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.